Stock Scorecard



Stock Summary for Amylyx Pharmaceuticals Inc (AMLX) - $1.76 as of 4/26/2024 8:53:23 PM EST

Total Score

23 out of 29

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Strong Buy

Growth List Algorithm Criteria for AMLX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AMLX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AMLX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for AMLX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for AMLX

Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP - Amylyx Pharma ( NASDAQ:AMLX ) , Hut 8 ( NASDAQ:HUT ) 4/15/2024 3:21:00 PM
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals 4/12/2024 1:22:00 PM
InnovationRx: $90 Million To Make Drugs In Space 4/10/2024 10:52:00 PM
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News 4/10/2024 5:19:00 PM
DEADLINE ALERT for XPOF, LUXH, and AMLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Amylyx Pharma ( NASDAQ:AMLX ) , LuxUrban Hotels ( NASDAQ:LUXH ) 4/9/2024 4:12:00 PM
Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline - Amylyx Pharma ( NASDAQ:AMLX ) 4/8/2024 10:24:00 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - AMLX - Amylyx Pharma ( NASDAQ:AMLX ) 4/8/2024 3:12:00 PM
AMLX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX - Amylyx Pharma ( NASDAQ:AMLX ) 4/8/2024 2:04:00 PM
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc. ( AMLX ) Shareholders 4/8/2024 9:45:00 AM
AMLX 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Amylyx Pharmaceuticals ( AMLX ) Investors with Substantial Losses to Contact Firm Before Apr. 9th Deadline in Securities Fraud Class Action - Amylyx Pharma ( NASDAQ:AMLX ) 4/7/2024 5:08:00 PM

Financial Details for AMLX

Company Overview

Ticker AMLX
Company Name Amylyx Pharmaceuticals Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 6/6/2024

Stock Price History

Last Day Price 1.76
Last Day Price Updated 4/26/2024 8:53:23 PM EST
Last Day Volume 5,216,779
Average Daily Volume 2,495,462
52-Week High 30.50
52-Week Low 1.76
Last Price to 52 Week Low 0.00%

Valuation Measures

Trailing PE 2.70
Industry PE 79.17
Sector PE 56.64
5-Year Average PE 3.42
Free Cash Flow Ratio 0.32
Industry Free Cash Flow Ratio 12.71
Sector Free Cash Flow Ratio 30.65
Current Ratio Most Recent Quarter 5.66
Total Cash Per Share 5.48
Book Value Per Share Most Recent Quarter 6.52
Price to Book Ratio 0.31
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.15
Price to Sales Ratio Twelve Trailing Months 0.34
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.17

Share Statistics

Total Shares Outstanding 67,782,000
Market Capitalization 119,296,320
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 124.84%
Reported EPS 12 Trailing Months 0.66
Reported EPS Past Year 0.00
Reported EPS Prior Year 0.70
Net Income Twelve Trailing Months 49,271,000
Net Income Past Year 49,271,000
Net Income Prior Year -198,375,000
Quarterly Revenue Growth YOY 395.50%
5-Year Revenue Growth 1,612.94%

Balance Sheet

Total Cash Most Recent Quarter 371,362,000
Total Cash Past Year 371,362,000
Total Cash Prior Year 346,945,000
Net Cash Position Most Recent Quarter 371,362,000
Net Cash Position Past Year 369,937,000
Long Term Debt Past Year 1,425,000
Long Term Debt Prior Year 1,425,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 433,432,000
Total Stockholder Equity Prior Year 340,607,000
Total Stockholder Equity Most Recent Quarter 433,432,000

Options

Put/Call Ratio 0.11
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.26
MACD Signal -1.60
20-Day Bollinger Lower Band -2.65
20-Day Bollinger Middle Band 10.56
20-Day Bollinger Upper Band 23.77
Beta -0.93
RSI 20.27
50-Day SMA 16.71
200-Day SMA 0.00

System

Modified 4/26/2024 5:44:38 PM EST